Article info
PDFInflammatory bowel disease
Original article
A blood-based prognostic biomarker in IBD
- Correspondence to Dr James C Lee and Professor Kenneth G C Smith, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0AW, UK; jcl65{at}cam.ac.uk, kgcs2{at}cam.ac.uk
Citation
A blood-based prognostic biomarker in IBD
Publication history
- Received January 22, 2019
- Revised March 11, 2019
- Accepted April 4, 2019
- First published April 27, 2019.
Online issue publication
July 05, 2019
Article Versions
- Previous version (27 April 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.